Skip to main content
EMPLICITI 300 mg/1 injection, powder, lyophilized, for solution by E.R. Squibb & Sons, L.L.C.
EMPLICITI, 300 mg/1, injection, powder, lyophilized, for solution Drug class: SLAMF7-directed Immunostimulatory Antibody. Available on prescription only. Listed by E.R. Squibb & Sons, L.L.C..
Prescription only

EMPLICITI

elotuzumab

Listed by E.R. Squibb & Sons, L.L.C.

Strength
300 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
SLAMF7-directed Immunostimulatory Antibody

What it contains

  • Elotuzumab 300 mg/1

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class SLAMF7-directed Immunostimulatory Antibody
Approval route BLA — biologic licence
NDC code 0003-2291
FDA application BLA761035
RxNorm concept 1726110
Package sizes listed 1
Marketed since November 2015

Other products containing Elotuzumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EMPLICITI

elotuzumab

Strength
400 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Class
SLAMF7-directed Immunostimulatory Antib…
Rx only

E.R. Squibb & Sons, L.L.C.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.